Renal function and lipid metabolism in Japanese HIV-1-positive individuals 288 weeks after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate: a single-center, retrospective cohort study

Abstract Background Continued use of tenofovir disoproxil fumarate (TDF), an antiretroviral drug, causes renal function decline and tubular damage in individuals with HIV. While tenofovir alafenamide fumarate (TAF) may have less damaging effects, it causes weight gain and abnormal lipid metabolism....

Celý popis

Podrobná bibliografie

Hlavní autoři:	Kensuke Abe, Junji Imamura, Akiko Sasaki, Tomoko Suzuki, Satomi Kamio, Taku Obara, Toshihiro Ito
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2024-02-01
Edice:	Journal of Pharmaceutical Health Care and Sciences
Témata:	Renal function Lipid metabolism HIV Tenofovir disoproxil fumarate Tenofovir alafenamide fumarate
On-line přístup:	https://doi.org/10.1186/s40780-024-00336-y
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!